Volume 63, Issue 1, Pages (January 2003)

Slides:



Advertisements
Similar presentations
Volume 59, Issue 4, Pages (April 2001)
Advertisements

Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model  Siska Mortier, Dirk Faict, Norbert.
Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.
l-Carnitine is an osmotic agent suitable for peritoneal dialysis
l-Carnitine is an osmotic agent suitable for peritoneal dialysis
Buffer transport in peritoneal dialysis
Volume 64, Issue 6, Pages (December 2003)
Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique.
D. Teta, M. Maillard, G. Halabi, M. Burnier  Kidney International 
Volume 62, Issue 2, Pages (August 2002)
Volume 68, Issue 6, Pages (December 2005)
l-Carnitine is an osmotic agent suitable for peritoneal dialysis
Regulation of apoptosis by lethal cytokines in human mesothelial cells
3,4-di-deoxyglucosone-3-ene promotes leukocyte apoptosis
Volume 63, Issue 2, Pages (February 2003)
Fluid overload and residual renal function in peritoneal dialysis: the proof of the pudding is in the eating  Wim Van Biesen, Achim Jörres  Kidney International 
Volume 59, Issue 5, Pages (May 2001)
Volume 59, Issue 1, Pages (January 2001)
Volume 60, Issue 5, Pages (November 2001)
Volume 58, Issue 1, Pages (July 2000)
Volume 64, Issue 5, Pages (November 2003)
Volume 57, Issue 6, Pages (June 2000)
E. Boulanger, N. Grossin, M.-P. Wautier, R. Taamma, J.-L. Wautier 
S.G. John, N.M. Selby, C.W. McIntyre  Kidney International 
Regulation of renal proximal tubular epithelial cell hyaluronan generation: Implications for diabetic nephropathy  Stuart Jones, Suzanne Jones, Aled Owain.
Glucose degradation products in peritoneal dialysis fluids: Do they harm?  Janusz Witowski, Achim Jörres, Katarzyna Korybalska, Krzysztof Ksiazek, Justyna.
Volume 86, Issue 6, Pages (December 2014)
Volume 60, Issue 3, Pages (September 2001)
Chemical and hormonal determinants of vascular calcification in vitro
Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.
Analysis of fluid transport pathways and their determinants in peritoneal dialysis patients with ultrafiltration failure  A. Parikova, W. Smit, D.G. Struijk,
The application of animal models to study the biocompatibility of bicarbonate-buffered peritoneal dialysis solutions  P.M. ter Wee, R.H.J. Beelen, J.
Volume 54, Issue 6, Pages (January 1998)
Volume 62, Issue 2, Pages (August 2002)
In vitro biocompatibility performance of Physioneal
Volume 76, Issue 6, Pages (September 2009)
Bone mass evolution after renal transplantation
Volume 68, Issue 3, Pages (September 2005)
Volume 65, Issue 3, Pages (March 2004)
Simvastatin increases fibrinolytic activity in human peritoneal mesothelial cells independent of cholesterol lowering  Bettina Haslinger, Martin F. Goedde,
Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model  Siska Mortier, Dirk Faict, Norbert.
Volume 62, Issue 2, Pages (August 2002)
Volume 66, Issue 3, Pages (September 2004)
Volume 60, Issue 6, Pages (December 2001)
Eva Balint, Cory F. Marshall, Dr Stuart M. Sprague 
Nitric oxide inhibits the formation of advanced glycation end products
Angiotensin II stimulates Pax-2 in rat kidney proximal tubular cells: Impact on proliferation and apoptosis  Shao-Ling Zhang, Jun Guo, Babak Moini, Julie.
Ho Jae Han, Soo Hyun Park, Hyun Ju Koh, Mary Taub  Kidney International 
Volume 73, Pages S72-S75 (April 2008)
Volume 61, Issue 2, Pages (February 2002)
Volume 64, Pages S84-S93 (December 2003)
Ken Inoki, Masakazu Haneda, Shiro Maeda, Daisuke Koya, Ryuichi Kikkawa 
Volume 64, Issue 6, Pages (December 2003)
Quality of life in peritoneal dialysis patients: Decline over time and association with clinical outcomes  Sr. Anne B. Bakewell, Rob M. Higgins, Mair.
Lu-Cheng Cao, Thomas Honeyman, Julie Jonassen, Cheryl Scheid 
Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue- type plasminogen activator  Thomas Sitter, Karin Toet, Paul.
Peter G. Blake, Arsh K. Jain, Sechelle Yohanna  Kidney International 
Volume 62, Issue 3, Pages (September 2002)
Volume 63, Issue 1, Pages (January 2003)
Biocompatibility of icodextrin
Volume 59, Issue 4, Pages (April 2001)
Charles A. Herzog  Kidney International 
Quantification of free water transport in peritoneal dialysis
Effects of hyperglycemia on the differential expression of insulin and insulin-like growth factor-I receptors in human normal peritoneal and adhesion.
Volume 54, Issue 4, Pages (October 1998)
Volume 65, Issue 1, Pages (January 2004)
The International Pediatric Peritonitis Registry: Starting to walk
The biocompatibility of neutral pH, low-GDP peritoneal dialysis solutions: benefit at bench, bedside, or both?  Jeffrey Perl, Sharon J. Nessim, Joanne.
Volume 57, Issue 6, Pages (June 2000)
Volume 71, Issue 8, Pages (April 2007)
Presentation transcript:

Volume 63, Issue 1, Pages 331-339 (January 2003) Affinity adsorption of glucose degradation products improves the biocompatibility of conventional peritoneal dialysis fluid  Naoyoshi Ishikawa, Toshio Miyata, Yasuhiko Ueda, Reiko Inagi, Yuko Izuhara, Hiroko Yuzawa, Hiroshi Onogi, Makoto Nishina, Masaomi Nangaku, Charles van Ypersele de Strihou, Kiyoshi Kurokawa  Kidney International  Volume 63, Issue 1, Pages 331-339 (January 2003) DOI: 10.1046/j.1523-1755.2003.00732.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Changes in GO, MGO and 3-DG levels elicited in conventional PD fluid by the addition of diaminoguanidine (A) and L-cysteine (B).Abbreviations are in the Appendix. Heat-sterilized 1.36% glucose PD fluid (pH 5.2) was incubated for one hour at room temperature with various concentrations of either diaminoguanidine or l-cysteine [(□) 1 mmol/L, (▵) 5 mmol/L, (○) 10 mmol/L] dissolved in 0.1 mol/L sodium phosphate buffer, pH 7.4. The GO, MGO, and 3-DG levels were determined by a reverse HPLC. Data are expressed as percentage of the levels initially present in fresh PD fluid. They represent the mean ± SD of the three independent experiments. Kidney International 2003 63, 331-339DOI: (10.1046/j.1523-1755.2003.00732.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 2 Changes of GO, MGO and 3-DG levels elicited in conventional PD fluid by the addition of diaminoguanidine-coupled or hydrazine-coupled epoxy-beads. Heat-sterilized 1.36% glucose PD fluid (pH 5.5) was incubated for one hour at room temperature with 0.13 g dried diaminoguanidine-coupled (▪) or hydrazine-coupled epoxy-beads (•). GO, MGO, and 3-DG were determined by a reverse HPLC. Data are expressed as percentage of the levels initially present in fresh PD fluid. They represent the mean ± SD of three independent experiments. **P < 0.05, *P < 0.001 when compared with hydrazine-coupled epoxy-beads. Kidney International 2003 63, 331-339DOI: (10.1046/j.1523-1755.2003.00732.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 3 Changes of total carbonyl concentration in PD effluents elicited by the addition of hydrazine-coupled epoxy-beads. PD effluents after an eight hour dwell, obtained from patients undergoing PD with 1.36% glucose PD fluid, were incubated for one hour at room temperature with 0.13 g dried hydrazine-coupled epoxy-bead. After ultrafiltration through a filter with a 5000 D cut-off value, the sample was incubated with DNPH, and RCOs (other than glucose) were determined by a spectrophotometric assay. Samples processed similarly but without DNPH treatment were used as blanks. Data from three PD patients are expressed as mean ± SD. **P < 0.05 vs. compared with untreated PD effluent. Kidney International 2003 63, 331-339DOI: (10.1046/j.1523-1755.2003.00732.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 4 Effects of hydrazine-coupled epoxy-bead treated PD fluid or an RCO solution on the viability of A431 cells and of primary cultured human peritoneal mesothelial cells (HMC). A431 cells (A) or HMC (B) were cultured in the presence of either filter-sterilized (pH 6.4), or heat-sterilized (pH 5.2) PD fluids treated with hydrazine-coupled epoxy-bead (pH 5.9), or heat-sterilized PD fluid adjusted to pH 5.9. After a 3 hour (A431) or 12 hour (HMC) culture, the incubation medium was replaced by fresh culture medium for the subsequent 18 hours. The viability of cells was then determined. Results are expressed as percentage of control (medium alone) and represent the mean ± SD of three independent experiments. **P < 0.05, *P < 0.001 vs. heat-sterilized PD fluid (pH 5.2). ‡P < 0.05 vs. heat-sterilized PD fluids treated with hydrazine-coupled epoxy-bead. There is no significant difference between filter-sterilized PD fluids and heat-sterilized PD fluids treated with hydrazine-coupled epoxy-bead. A431 cells or HMC (C) were cultured in the presence of a RCO solution (10 μmol/L GO, MGO, and 3-DG and 10% FBS in the medium, pH 7.4), and the viability of cells was determined. Results are expressed as percentage of control (medium alone) and represent the mean ± SD of three independent experiments. **P < 0.05, *P < 0.001 vs. control medium. Kidney International 2003 63, 331-339DOI: (10.1046/j.1523-1755.2003.00732.x) Copyright © 2003 International Society of Nephrology Terms and Conditions